Main menu

Skip to primary content
Skip to secondary content
  • Home
  • Products
  • People
    • Our Board of Directors
    • Our Leadership Team
    • Our Story
    • Our Values
  • Our Focus
    • Business Development
    • In the Hospital Enviornment
  • Working at Cadence
    • Benefits
    • Join Our Team
    • Our Values
    • Working At Cadence
  • Investors
    • Analysts
    • Board of Directors &
      Committee Composition
    • Contact Us
    • Corporate Governance
    • Email Alerts
    • Essential Governance
      Documents
    • Events & Presentations
    • Financial Reports
    • Historic Stock Look-up
    • Information Request
    • Investor Relations
    • Management
    • Press Releases
    • SEC Filings
    • Stock Information
  • Contact Us

Cadence Pharmaceuticals

Improving lives of hospitalized patients

Essential Governance Documents

Essential Governance Documents

Document View
Audit Committee Charter HTML PDF   23.0 KB Add to Briefcase
Compensation Committee Charter HTML PDF   16.9 KB Add to Briefcase
Nominating/Corporate Governance Committee Charter HTML PDF   13.8 KB Add to Briefcase
Corporate Governance Guidelines HTML PDF   21.9 KB Add to Briefcase
Code of Business Conduct and Ethics HTML PDF   25.5 KB Add to Briefcase


Add to Briefcase = add file to Briefcase
Print page Print
Email page Email

Stock Quote
CADX - (NASDAQ)
$7.18   - 0.10
May 17, 2013
4:06 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by eSignal.

  • Investor Relations
  • Press Releases
  • Events & Presentations
    • Corporate Overview
      Updated May 2, 2013
    • Analyst & Investor Day
      Updated December 6, 2012
  • SEC Filings
  • Financial Reports
  • Corporate Governance
    • Management
    • Board of Directors &
      Committee Composition
    • Essential Governance
      Documents
  • Stock Information
    • Historic Stock Look-up
    • Analysts
  • Information Request
    • Email Alerts
  • Contact Us
"We hold ourselves accountable for possessing and maintaining high
standards of quality and uncompromised ethics." Ted Schroeder

News Room

May 8, 2013 Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013 May 2, 2013 Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results Read more

Core Values

At Cadence, we are guided by a set of core values that communicate what is most important to us. Performance Driven Transparency Integrity Respect
Home Products People Our Focus Working at Cadence Investors Careers Contact Us Terms of Use Corporate Compliance Privacy policy
© 2013 Cadence Pharmaceuticals Inc. All rights reserved.